You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Daily Injections (MDI)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type1diabetes Trial in Petach Tikva, Petah-Tikva (DreaMed Advisor Pro DSS-MDI algorithm)

Recruiting
  • Type1diabetes
  • DreaMed Advisor Pro DSS-MDI algorithm
  • Petach Tikva, Israel
  • +1 more
Aug 15, 2022

Type 1 Diabetes With Hypoglycemia Trial (DailyDose Smart Snack app, Dexcom G6 CGM)

Not yet recruiting
  • Type 1 Diabetes Mellitus With Hypoglycemia
  • DailyDose Smart Snack app
  • Dexcom G6 CGM
  • (no location specified)
Jul 21, 2023

Type 1 Diabetes Trial in Seongnam-si, Seoul (DIA:CONN G8 insulin pump, Multiple daily insulin injection)

Recruiting
  • Type 1 Diabetes
  • DIA:CONN G8 insulin pump
  • Multiple daily insulin injection
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Feb 15, 2022

Diabetes, Type 1 Trial in Belgium, France, United Kingdom (Omnipod 5 System)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Omnipod 5 System
  • Leuven, Belgium
  • +16 more
Jun 20, 2023

Type 1 Diabetes Trial in Verona (Use of Predictive Alarm for hypoglycaemia or hyperglycaemia, Use of Alarm on Threshold for

Completed
  • Type 1 Diabetes
  • Use of Predictive Alarm for hypoglycaemia or hyperglycaemia
  • Use of Alarm on Threshold for hypoglycaemia or hyperglycaemia
  • Verona, Italy
    Pediatric Diabetes and Metabolic Disorders Unit, Surgery, Dentis
Oct 7, 2022

Type 2 Diabetes Trial in Seoul (FreeStyle Libre, SMBG)

Recruiting
  • Type 2 Diabetes Mellitus
  • FreeStyle Libre
  • SMBG
  • Seoul, Korea, Republic of
    Samsung Medical Center
Dec 21, 2021

Insulin-dependent Diabetes, Diabetes, Type 1 Trial in Petah Tikva (Advisor Pro)

Completed
  • Insulin-dependent Diabetes Mellitus
  • Diabetes Mellitus, Type 1
  • Advisor Pro
  • Petah Tikva, Israel
    Schneider MC
Aug 16, 2021

Type 1 Diabetes Trial in Doha (Medtronic Minimed 670G insulin pump)

Unknown status
  • Type 1 Diabetes
  • Medtronic Minimed 670G insulin pump
  • Doha, Qatar
    Hamad Medical Corporation
Feb 18, 2021

Diabetes, Type 1 Trial in Worldwide (Accu-Chek® Solo micropump system, mylife™ OmniPod® Insulin Management System, Multiple

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Accu-Chek® Solo micropump system
  • +2 more
  • Feldkirch, Austria
  • +20 more
Aug 19, 2021

Type 1 Diabetes, Multiple Daily Injections Trial in Petach-Tikva (MPSA Algorithm)

Terminated
  • Type 1 Diabetes
  • Multiple Daily Injections
  • MPSA Algorithm
  • Petach-Tikva, Israel
    Schnider children medical center
Nov 29, 2020

Poor Glycemic Control, Quality of Life Trial in Leuven (accu chek Aviva Expert, Accu Chek Aviva Nano)

Completed
  • Poor Glycemic Control
  • Quality of Life
  • accu chek Aviva Expert
  • Accu Chek Aviva Nano
  • Leuven, Belgium
    UZLeuven
Nov 16, 2023

Type 1 Diabetes, Insulin-requiring Type 2 Diabetes, End Stage Renal Disease (ESRD) Trial (Artificial Pancreas, Multiple Daily

Withdrawn
  • Type 1 Diabetes
  • +2 more
  • Artificial Pancreas
  • Multiple Daily Injections
  • (no location specified)
Nov 2, 2021

Type 2 Diabetes, Pregnancy in Diabetic Trial in Beijing (Continuous subcutaneous insulin infusion (CSII), Multiple daily insulin

Not yet recruiting
  • Type 2 Diabetes
  • Pregnancy in Diabetic
  • Continuous subcutaneous insulin infusion (CSII)
  • Multiple daily insulin injection (MDI)
  • Beijing, Beijing, China
    Peking University Third Hospital
Nov 28, 2021

Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)

Recruiting
  • Type 2 Diabetes
  • Cleveland, Ohio
    Cleveland Clinic
Jul 18, 2022

Diabetes, Type 1 Trial in Aurora (Technosphere insulin)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Technosphere insulin
  • Aurora, Colorado
    Barbara Davis Center
Jan 28, 2022

Type 1 Diabetes Trial in Aurora (Multiple daily ijnection using Insulin Degludec and Insulin Aspart)

Completed
Has Results
  • Type 1 Diabetes
  • Multiple daily ijnection using Insulin Degludec and Insulin Aspart
  • Aurora, Colorado
    Barbara Davis Center for Diabetes
Sep 9, 2021

Type 1 Diabetes Trial in Worldwide (670G and 770G Insulin Pump, Subject's Current Diabetes Therapy)

Recruiting
  • Type 1 Diabetes
  • 670G and 770G Insulin Pump
  • Subject's Current Diabetes Therapy
  • La Jolla, California
  • +37 more
Jul 14, 2022

Type 1 Diabetes Trial in Rennes (A decision support software)

Completed
  • Type 1 Diabetes
  • A decision support software
  • Rennes, France
    CHU de Rennes
Aug 19, 2022

Green Digital Diabetes Waste Project

Recruiting
  • Diabetes Mellitus
  • +2 more
    • Burlingame, California
    • +1 more
    Oct 3, 2023

    Type 1 Diabetes Trial in Montreal (Sensor augmented MDI therapy plus mobile application)

    Recruiting
    • Type 1 Diabetes
    • Sensor augmented MDI therapy plus mobile application
    • Montreal, Quebec, Canada
      Clinique Médicale Hygea
    Apr 19, 2022

    Type 1 Diabetes Trial in France, Germany, United Kingdom (MDI, AHCL)

    Active, not recruiting
    • Type 1 Diabetes
    • MDI
    • AHCL
    • Besançon, France
    • +13 more
    Dec 17, 2021

    Regarding Glucose Metrics, Sleep, and Health Economics

    Completed
    • Type 1 Diabetes
    • Tandem Control-IQ
    • Kungsbacka, Region Of Halland, Sweden
      The hospital of Halland Kungsbacka
    Jul 28, 2023

    Type 2 Diabetes Trial in Cambridge (CamAPS HX Closed-loop, Multiple Daily Insulin Injections (Control))

    Completed
    • Type 2 Diabetes
    • CamAPS HX Closed-loop
    • Multiple Daily Insulin Injections (Control)
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    May 25, 2022

    Type 1 Diabetes Trial in United Kingdom (CSII (Insulin Pump) plus DAFNE, MDI (levemir® & quick acting insulin) plus DAFNE)

    Completed
    • Type 1 Diabetes
    • CSII (Insulin Pump) plus DAFNE
    • MDI (levemir® & quick acting insulin) plus DAFNE
    • Cambridge, Cambridgeshire, United Kingdom
    • +7 more
    Jan 22, 2021

    Type 2 Diabetes Trial in Fresno (GLP1 receptor agonist, basal insulin, SGLT2 inhibitor)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • GLP1 receptor agonist
    • +3 more
    • Fresno, California
      UCSF Fresno
    Oct 20, 2020